← Back to Search

Time-Restricted Feeding for Fanconi Anemia

N/A
Recruiting
Led By Stella Davies, MBBS, PhD, MRCP
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 12 years old
Diagnosis of FA with neuroinflammation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will study whether time-restricted eating reduces inflammation & improves function in people with Fanconi anemia & neurological changes. Participants will eat for 8 hrs/day.

Who is the study for?
This trial is for individuals aged 12 or older who have been diagnosed with Fanconi anemia, specifically those experiencing neuroinflammation. There are no specific exclusion criteria mentioned, so it appears open to anyone meeting the age and diagnosis requirements.Check my eligibility
What is being tested?
The study is testing if eating within an 8-hour window each day (time-restricted feeding) can reduce inflammation and improve neurological function in people with Fanconi anemia.See study design
What are the potential side effects?
Since this trial involves a dietary intervention rather than medication, side effects may include hunger outside of the eating window, potential changes in energy levels, and possible adjustment-related digestive issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 12 years old or older.
Select...
I have been diagnosed with FA and have inflammation in my nervous system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with neuroinflammation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Time-Restricted FeedingExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time-Restricted Feeding
2019
N/A
~200

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,581 Total Patients Enrolled
9 Trials studying Fanconi Anemia
250 Patients Enrolled for Fanconi Anemia
Stella Davies, MBBS, PhD, MRCPPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
5 Previous Clinical Trials
2,148 Total Patients Enrolled

Media Library

Time-Restricted Feeding Clinical Trial Eligibility Overview. Trial Name: NCT05598515 — N/A
Fanconi Anemia Research Study Groups: Time-Restricted Feeding
Fanconi Anemia Clinical Trial 2023: Time-Restricted Feeding Highlights & Side Effects. Trial Name: NCT05598515 — N/A
Time-Restricted Feeding 2023 Treatment Timeline for Medical Study. Trial Name: NCT05598515 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this clinical investigation?

"Indeed, clinicaltrials.gov data states that this medical trial is actively recruiting patients. The experiment was initially published on November 11th 2022 with the most recent update issued on November 25th 2022."

Answered by AI

How many participants are receiving the opportunity to take part in this study?

"Affirmative. According to clinicaltrials.gov, this medical trial is in the process of recruiting participants after initially being posted on November 11th 2022 and most recently updated on November 25th 2022. It needs 10 individuals from a single location to complete the study."

Answered by AI
~5 spots leftby Oct 2025